(Q413879)

Statements

instance of

type of chemical entity

0 references

subclass of

chemical compound

0 references

has use

medication

1 reference

title

golimumab (English)

stated in

DrugBank

language of work or name

English

publication date

17 November 2015

DrugBank ID

06674

image of molecular model or crystal lattice model

Golimumab 5yoy.png
640 × 480; 93 KB

depicts

ribbon diagram

0 references

defined daily dose

1.66 milligram

route of administration

parenteral route of administration

1 reference

reference URL

https://www.whocc.no/atc_ddd_index/?code=L04AB06

active ingredient in

Simponi

1 reference

European Medicines Agency product number

EMEA/H/C/000992

reference URL

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000992/human_med_001053.jsp

retrieved

22 March 2017

World Health Organisation international non-proprietary name

golimumab (English)

1 reference

stated in

ChEMBL

ChEMBL ID

CHEMBL1201833

language of work or name

English

title

golimumab (English)

retrieved

19 January 2016

medical condition treated

polyarthritis

1 reference

stated in

Drug Indications Extracted from FAERS

retrieved

2 October 2018

colitis

1 reference

stated in

Drug Indications Extracted from FAERS

retrieved

2 October 2018

ankylosing spondylitis

1 reference

stated in

Drug Indications Extracted from FAERS

retrieved

2 October 2018

arthritis

1 reference

stated in

Drug Indications Extracted from FAERS

retrieved

2 October 2018

ulcerative colitis

1 reference

stated in

Drug Indications Extracted from FAERS

retrieved

2 October 2018

spondylitis

1 reference

stated in

Drug Indications Extracted from FAERS

retrieved

2 October 2018

significant drug interaction

anakinra

side effect

neutropenia

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

legal status (medicine)

boxed warning

1 reference

reference URL

https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/343802

title

FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links. (English)

LiverTox likelihood score

LiverTox toxicity likelihood category E*

1 reference

stated in

LiverTox

retrieved

8 April 2021

reference URL

https://www.ncbi.nlm.nih.gov/books/n/livertox/Golimumab

last update

10 February 2017

has characteristic

biopharmaceutical

1 reference

title

golimumab (English)

stated in

DrugBank

language of work or name

English

publication date

17 November 2015

DrugBank ID

06674

subject has role

immunologic factor

1 reference

stated in

NDF-RT

NDF-RT ID

N0000178413

retrieved

5 March 2018

monoclonal antibody

1 reference

stated in

DrugBank

DrugBank ID

06674

language of work or name

English

title

golimumab (English)

publication date

17 November 2015

Identifiers